Clinical Trials in Nashville

Showing 14101-14120 of 20,298 trials

A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer

NCT02083185

The purpose of this study is to evaluate the efficacy of TAK 385 for achieving and maintaining testosterone suppression (\<50 ng/dL).

Prostate Cancer

Millennium Pharmaceuticals, Inc.136 participantsStarted Mar 2014

Birmingham, Alabama, United States • San Diego, California, United States • Denver, Colorado, United States +20 more locations

COMPLETEDPhase 2< 1 mile

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

NCT01126970

To evaluate the weight loss effect and safety of 400 mg velneperit and 120 mg orlistat administered individually or combined three times per day for 24 weeks while on a reduced calorie diet (RCD) and also to evaluate the steady-state trough concentrations of velneperit (S-2367), velneperit (S-2367) tert-butyl OH, and velneperit (S-2367) tert-butyl OH-O glucuronide following 400 mg of velneperit (S-2367) three times per day and 120 mg of orlistat, either combined or separate.

Obesity

Shionogi486 participantsStarted Apr 2010

Santa Rosa, California, United States • Waterbury, Connecticut, United States • Clearwater, Florida, United States +22 more locations

A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Find Trials by Condition in Nashville

Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors

Delirium in the Emergency Department: Novel Screening

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

LINX Reflux Management System Clinical Study Protocol

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol